Arkolith/Insider Trading/TENX/Form 4

Davidson Michael H.

DirectorTENAX THERAPEUTICS, INC. (TENX) · full profile →Form 4 · filed Aug 8, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2024Buy(P)3K——3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 8, 2024Buy(P)48K——48K
Aug 8, 2024Buy(P)25K——25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-24-010192) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML